Abstract:BACKGROUND & OBJECTIVE:In recent years, the neoadjuvant chemotherapy for cervical cancer has evoked more and more attention and has been used widely. But the chemosensitivity of individuals to various antitumor drugs is different. This study was to investigate the chemosensitivity of cervical cancer cells to antitumor drugs using in vitro MTT assay chemosensitivity test. METHODS:The sensitivity of fresh human cervical cancer cells from 32 patients to 9 cytotoxic drugs was tested using in vitro MTT assay. RESULTS:The cytotoxic activities of the 9 drugs for cervical cancer were in sequence from high to low as follows: liposomal paclitaxel, taxol, carboplatin (CBP), ifosfamide (IFO), etoposide (VP-16), 5-fluorouracil (5-FU), cisplatin (DDP), bleomycin (BLM), and cyclophosphamide (CTX). Generally, cervical cancer cells were more sensitive to paclitaxel, taxol, and CBP than to other drugs (P<0.05) with inhibition rates of 56.56%, 55.66%, and 46.81%, respectively. Stage Ib1 cervical cancer cells were more sensitive to taxol, paclitaxel, and CBP than to other drugs with inhibition rates of 58.71%, 53.00%, and 49.25%, respectively; stage Ib2 cervical cancer cells were more sensitive to paclitaxel and taxol than to other drugs with inhibition rates of 65.26% and 50.06%. Both moderately and poorly differentiated squamous cell cancer cells were more sensitive to taxol, paclitaxel, and CBP than to other drugs with inhibition rates of 52.01%, 49.21%, and 40.02% for the former, and 60.02%, 61.16%, and 48.75% for the latter. CONCLUSIONS:MTT assay, a sensitive and widely used chemosensitivity testing method, is helpful in sensitive drug screening and neoadjuvant chemotherapy regimen selection for cervical cancer. Cervical cancer cells are more sensitive to paclitaxel, taxol, and CBP than to other tested drugs in this study.

[Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].

Study on susceptibility of eight common chemotherapy drug combinations in human cervical carcinoma cell in vitro

Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations

Detection of Chemosensitivity of Cervical Carcinoma in Vitro by MTT Assay and Its Clinical Significance

Predictive Chemotherapy of Advanced Breast Cancer Directed by MTT Assay in Vitro

Evaluation of the in Vitro Chemosensitivity and Correlation with Clinical Outcomes in Lung Cancer Using the ATP-TCA.

Analysis on the Detected Chemotherapeutic Drug Sensitivity Results of Gastric Cancer Cells by Using MTT Method

Study of chemosensitivity for human breast cancer cells cultivated in primary generation in vitro

Chemosensitivity in vitro of 25 anti-cancer drugs to primary cultured human breast cancer cells

Profiling Protein Markers Associated with the Sensitivity to Concurrent Chemoradiotherapy in Human Cervical Carcinoma.

MTT measuring drug sensitivity of cancer cells and its relationship with clinical prescription

[Experimental study of sensitivity to chemotherapeutic agents for human endometrial carcinoma cell line]

Clinical Study on Sensitivity of Oral and Maxillofacial Cancers with Chemotherapy

An Evaluation of the Sensitivity of Chemotherapeutical Agents to Breast Cancer by MTT Assay in Vitro

Relationship Between the Expression of P27~(kip1) and Chemosensitivity of Cervical Carcinoma in Vitro

Analysis of Drug Sensitivity and Its Guidance in Clinic in 61 Cases of Breast Cancer Cell

Chemosensitivity Testing of Oral and Maxillofacial Cancer with Biopsy Specimens

Research and Exploratory of Chemotherapy Drugs Sensitivity Tests in Liver Cancer

Chemosensitivity of Human Glioma in Vitro by MTT Method

[Chemotherapy guidance of the drug sensitivity test in vitro in human laryngeal squamous cell carcinoma]

Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling.